Literature DB >> 9529058

Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A.

S P Li1, S I Lee, J E Domer.   

Abstract

We have shown previously that intravenous injection of Candida albicans mannan (MAN) into naive mice induced CD8+ effector downregulatory cells and that such cells were not produced if mice were deficient in CD4+ or I-A+ cells during the early interval (< or =30 h) following the introduction of MAN. Moreover, the nonspecific biological response modifier monophosphoryl lipid A (MPL), given in vivo or incubated with cells in vitro, can abrogate the MAN-specific immunomodulatory activity. The mechanism by which the abrogation is mediated is unknown, but it is hypothesized to involve cytokines. Therefore, we measured the number of cytokine-secreting cells for the Thl cytokine interleukin-2 (IL-2) and the Th2 cytokine IL-4, as well as for gamma interferon (IFN-gamma), in splenocyte populations from MAN and/or MPL-treated mice, using an enzyme-linked immunospot assay designed to detect individual cytokine-secreting cells (spot-forming cells [SFC]). Cytokine-secreting cells were demonstrated in cell suspensions enriched for CD4+ cells, but no SFC could be demonstrated in populations enriched for CD8+ cells. Both MAN and MPL, when administered to separate groups of animals, stimulated the production of increased numbers of cytokine-producing cells for each of the three cytokines tested. The response with respect to IL-4-secreting cells, however, was the most striking. Despite the fact that MAN and MPL independently caused increases in SFC to all three cytokines, when both MAN and MPL were administered to the same animal, all increases were reversed, and the numbers of SFC detected were at or below those detected in saline control animals. These data support the hypothesis that IL-4 is involved in MAN-specific immunoregulatory activities. The data also emphasize the fact that two immunomodulators, i.e., MAN and MPL, having similar effects when given in vivo independently, may be antagonistic when administered sequentially to the same animal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529058      PMCID: PMC108065     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  Suppressor T cells: some answers but more questions.

Authors:  M E Dorf; V K Kuchroo; M Collins
Journal:  Immunol Today       Date:  1992-07

Review 2.  Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo.

Authors:  R L Coffman; K Varkila; P Scott; R Chatelain
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

3.  Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum.

Authors:  R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.

Authors:  A Vecchiarelli; M Puliti; A Torosantucci; A Cassone; F Bistoni
Journal:  Cell Immunol       Date:  1991-04-15       Impact factor: 4.868

Review 5.  Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

Authors:  A Sher; R T Gazzinelli; I P Oswald; M Clerici; M Kullberg; E J Pearce; J A Berzofsky; T R Mosmann; S L James; H C Morse
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

6.  Cytokine-specific ELISPOT assay. Single cell analysis of IL-2, IL-4 and IL-6 producing cells.

Authors:  K Fujihashi; J R McGhee; K W Beagley; D T McPherson; S A McPherson; C M Huang; H Kiyono
Journal:  J Immunol Methods       Date:  1993-04-02       Impact factor: 2.303

7.  Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

Authors:  J E Domer; L G Human; G B Andersen; J A Rudbach; G L Asherson
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans.

Authors:  E Cenci; L Romani; A Mencacci; R Spaccapelo; E Schiaffella; P Puccetti; F Bistoni
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  In vivo modulation of lymphokine-activated killer cell activity by cell wall components of Candida albicans.

Authors:  L Scaringi; E Rosati; P Cornacchione; R Rossi; P Marconi
Journal:  Cell Immunol       Date:  1992-02       Impact factor: 4.868

10.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  3 in total

1.  Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

Authors:  A L Baltch; R P Smith; M A Franke; W J Ritz; P B Michelsen; L H Bopp
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Authors:  Y Wang; S P Li; S A Moser; K L Bost; J E Domer
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 3.  How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?

Authors:  Josué da Costa Lima-Junior; Fernanda Nazaré Morgado; Fátima Conceição-Silva
Journal:  Cells       Date:  2017-09-29       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.